The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children

Lisa B Mahoney1, Samuel Nurko1, Rachel Rosen1

  • 1Aerodigestive and Motility and Functional Gastrointestinal Disorders Centers, Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA.

Insights

Functional heartburn is the most common Rome IV nonerosive esophageal phenotype in children. Microscopic esophagitis and proton pump inhibitor (PPI) responsiveness do not predict these pediatric phenotypes.

Area of Science:

  • Pediatric Gastroenterology
  • Esophageal Physiology
  • Gastrointestinal Motility Disorders

Background:

  • Nonerosive esophageal phenotypes are increasingly recognized in pediatric gastroesophageal reflux disease (GERD).
  • Accurate classification of these phenotypes is crucial for effective management.
  • Rome IV criteria provide a framework for diagnosing functional gastrointestinal disorders, including nonerosive esophageal conditions.

Purpose of the Study:

  • To determine the prevalence of Rome IV nonerosive esophageal phenotypes in children.
  • To evaluate proton pump inhibitor (PPI) responsiveness in these pediatric patients.
  • To assess the frequency of microscopic esophagitis in children with nonerosive esophageal phenotypes.

Main Methods:

  • Retrospective review of pediatric patients (≥5 years) undergoing esophagogastroduodenoscopy and multichannel intraluminal impedance testing.
  • Exclusion of patients on PPI therapy; inclusion of those with symptoms during testing.
  • Categorization into nonerosive reflux disease, reflux hypersensitivity, and functional heartburn based on Rome IV criteria.

Main Results:

  • Functional heartburn was the most prevalent phenotype (44%), followed by reflux hypersensitivity (29%) and nonerosive reflux disease (27%).
  • Older children reported more heartburn, while younger children experienced more nonspecific pain.
  • No significant differences were observed in PPI responsiveness or microscopic esophagitis across the phenotypes.

Conclusions:

  • Functional heartburn is the predominant Rome IV nonerosive esophageal phenotype in the pediatric population.
  • Microscopic esophagitis and PPI responsiveness are not reliable predictors of specific nonerosive esophageal phenotypes in children.
  • Further research may elucidate phenotype-specific treatment strategies for pediatric GERD.
Abstract

Related Concept Videos

Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
767
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.3K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.0K
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
685
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.0K